Jean-Claude B - Search Results

1

Discordance and Concordance Between Cerebrospinal and [¹⁸F]FDG-PET Biomarkers in Assessing Atypical and Early-Onset AD Dementia Cases.

Quispialaya KM, Therriault J, Aliaga A, Zimmermann M, Fernandez-Arias J, Lussier F, Massarweh G, Pascoal T, Soucy JP, Gauthier S, Jean-Claude B, Gilfix B, Vitali P, Rosa-Neto P. Quispialaya KM, et al. Among authors: jean claude b. Neurology. 2022 Nov 29;99(22):e2428-e2436. doi: 10.1212/WNL.0000000000201198. Epub 2022 Oct 20. Neurology. 2022. PMID: 36266044 Free PMC article.

2

Molecular analysis of the dual targeting of the epidermal growth factor receptor and the O⁶-methylguanine-DNA methyltransferase with a double arm hybrid molecule.

Rupp M, Mouhri ZS, Williams C, Jean-Claude BJ. Rupp M, et al. Oncotarget. 2018 Oct 12;9(80):35041-35055. doi: 10.18632/oncotarget.25120. eCollection 2018 Oct 12. Oncotarget. 2018. PMID: 30416678 Free PMC article.

3

Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5'-DFUR, the bioactive metabolite of Xeloda.

Ait-Tihyaty M, Rachid Z, Mihalcioiu C, Jean-Claude BJ. Ait-Tihyaty M, et al. Breast Cancer Res Treat. 2012 May;133(1):217-26. doi: 10.1007/s10549-011-1756-z. Epub 2011 Sep 14. Breast Cancer Res Treat. 2012. PMID: 21915635

4

Molecular analysis of the in vivo metabolism and biodistribution of metabolically and non-metabolically activated combi-molecules of the triazene class.

Qiu Q, Larroque AL, Gibbs B, Fang Y, Lakhrissi Y, Soucy JP, Mzengeza S, Rachid Z, Jean-Claude BJ. Qiu Q, et al. Drug Metab Lett. 2009 Jan;3(1):1-9. doi: 10.2174/187231209787176344. Drug Metab Lett. 2009. PMID: 19356110

5

Molecular Analysis of the Superior Efficacy of a Dual Epidermal Growth Factor Receptor (EGFR)-DNA-Targeting Combi-Molecule in Comparison with Its Putative Prodrugs 6-Mono-Alkylamino- and 6,6-Dialkylaminoquinazoline in a Human Osteosarcoma Xenograft Model.

Facchin C, Fraga-Timiraos AB, Schmitt J, Babaa N, Pannu N, Aliaga A, Larroque AL, Jean-Claude BJ. Facchin C, et al. Among authors: jean claude bj. Cells. 2023 Mar 16;12(6):914. doi: 10.3390/cells12060914. Cells. 2023. PMID: 36980255 Free PMC article.

6

Mechanisms and Antitumor Activity of a Binary EGFR/DNA-Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide.

Sharifi Z, Abdulkarim B, Meehan B, Rak J, Daniel P, Schmitt J, Lauzon N, Eppert K, Duncan HM, Petrecca K, Guiot MC, Jean-Claude B, Sabri S. Sharifi Z, et al. Clin Cancer Res. 2019 Dec 15;25(24):7594-7608. doi: 10.1158/1078-0432.CCR-19-0955. Epub 2019 Sep 20. Clin Cancer Res. 2019. PMID: 31540977

7

Performance of Knowledge-Based Radiation Therapy Planning for the Glioblastoma Disease Site.

Chatterjee A, Serban M, Abdulkarim B, Panet-Raymond V, Souhami L, Shenouda G, Sabri S, Jean-Claude B, Seuntjens J. Chatterjee A, et al. Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):1021-1028. doi: 10.1016/j.ijrobp.2017.07.012. Epub 2017 Jul 14. Int J Radiat Oncol Biol Phys. 2017. PMID: 28870791

8

Sensitivity to PRIMA-1MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 status.

Patyka M, Sharifi Z, Petrecca K, Mansure J, Jean-Claude B, Sabri S. Patyka M, et al. Oncotarget. 2016 Sep 13;7(37):60245-60269. doi: 10.18632/oncotarget.11197. Oncotarget. 2016. PMID: 27533246 Free PMC article.

9

Enhancement of the cytotoxic potential of the mixed EGFR and DNA-targeting 'combi-molecule' ZRBA1 against human solid tumour cells by a bis-quinazoline-based drug design approach.

Al-Safadi S, Domarkas J, Han Y, Brahimi F, Jean-Claude BJ. Al-Safadi S, et al. Anticancer Drugs. 2012 Jun;23(5):483-93. doi: 10.1097/CAD.0b013e328351c101. Anticancer Drugs. 2012. PMID: 22421369

10

Comparative studies between the effects of mitozolomide and two novel tetrazepinones PYRCL and QUINCL on NIH:OVCAR-3 cells.

Jean-Claude BJ, Mustafa A, Damian Z, De Marte J, Vasilescu DE, Yen R, Chan TH, Leyland-Jones B. Jean-Claude BJ, et al. Cancer Chemother Pharmacol. 1998;42(1):59-67. doi: 10.1007/s002800050785. Cancer Chemother Pharmacol. 1998. PMID: 9619759

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page